COGNITIVE PERFORMANCE - OCT 21 2026 - 17 MIN READ
Supplement for brain health UK: what works
Most of the brain health supplement market in the UK is noise. A small number of ingredients have genuine human trial data behind them, at specific doses, in specific forms. Creatine monohydrate at 5 g/day, for instance, raised brain phosphocreatine concentrations measurably in a 2021 review by Roschel et al. (2021). That kind of specificity is what separates a real signal from marketing copy.
A handful of ingredients have real human trial data at clinically relevant doses. The rest is speculation dressed up in scientific language, and knowing the difference is the whole game.
From this read
What the evidence actually shows
I want to be honest about the state of this field. It is genuinely exciting in places, and genuinely overhyped in others. The honest picture requires separating those two things.
Creatine is where I'd start. Forbes et al. (2022) published a systematic review covering creatine's effects on brain function and health across multiple populations. The consistent finding: creatine supplementation may raise brain phosphocreatine stores, and this appears to matter most when the brain is under metabolic stress, whether from sleep deprivation, ageing, or dietary restriction. The effect in well-rested, well-nourished young adults is smaller and less consistent. That nuance matters.
A 2023 randomised controlled trial by Sandkühler et al. (2023) found statistically significant improvements in memory and attention tasks following creatine supplementation versus placebo. The study was adequately powered and used a crossover design, which controls for individual variation. It is one of the cleaner trials in this space. Worth reading if you want to understand what "cognitive benefit" actually looks like in a controlled setting, rather than in a marketing claim.
DHA is the other ingredient with a firm regulatory footing in the UK. [GB-NHC] DHA contributes to the maintenance of normal brain function, authorised at a threshold of 250 mg/day. The 2025 review by Minihane (2025) covers omega-3 and brain health across life stages, with particular attention to midlife. The evidence for sustained DHA adequacy across adulthood is genuinely strong. The evidence for acute cognitive "enhancement" from DHA supplementation in already-replete individuals is much thinner, and I'd be overstating it to claim otherwise.
If you're looking at the broader picture of what drives cognitive function day to day, my piece on supplement for energy and focus covers the overlap between metabolic support and mental performance in more detail.
What's biologically happening: the mechanisms worth understanding
The brain accounts for roughly 20% of your resting energy expenditure despite being about 2% of body weight. It runs almost entirely on ATP, and it cannot store much of it. This is why the phosphocreatine shuttle matters for cognition. Phosphocreatine acts as a rapid buffer, donating its phosphate group to ADP to regenerate ATP within milliseconds. When brain creatine stores are higher, this buffer is larger.
Roschel et al. (2021) confirmed via magnetic resonance spectroscopy that oral creatine supplementation does raise brain phosphocreatine concentrations in humans. The mechanism is not hypothetical. The question is when it matters clinically, and the honest answer is: most clearly when baseline brain creatine is low, or when cognitive demand is high.
DHA operates through a different pathway entirely. It is a structural component of neuronal cell membranes, particularly in the phospholipid bilayer. Adequate DHA supports membrane fluidity, which affects receptor function, neurotransmitter signalling, and synaptic plasticity. The brain preferentially accumulates DHA over its adult life, and inadequate dietary intake over years, rather than weeks, is where the deficit tends to appear. This is why the GB-NHC authorised claim is framed around "maintenance of normal brain function" rather than acute enhancement. The biology supports that framing.
Citicoline (CDP-choline) is worth understanding mechanistically, even though the large-scale human trial data is still limited. It serves as a precursor to phosphatidylcholine, a key membrane phospholipid, and also donates choline for acetylcholine synthesis. The hypothesis is that maintaining adequate choline status supports neurotransmitter production and membrane repair. Research is ongoing and large-scale RCTs in healthy adults are limited, so I hold this at a mechanistic tier rather than a confirmed efficacy claim.
The gut-brain axis is a genuinely emerging area. Loh et al. (2024) reviewed the evidence on microbiota-gut-brain signalling in the context of neurodegenerative disease. The bidirectional communication via the vagus nerve, immune signalling, and short-chain fatty acid production is real biology. Whether it translates into actionable supplementation strategies for healthy adults is a different question, and the honest answer is: not clearly yet.
Dosing: what the clinical evidence actually requires
This is where most products fail, and where specification literacy pays off.
For creatine, the trials showing measurable brain phosphocreatine elevation used 5 g/day of creatine monohydrate consistently. Candow et al. (2023) reviewed the evidence for brain-specific applications and noted that doses below 3 g/day produce inconsistent brain uptake. If a product lists creatine at 1 or 2 g, it is not the dose that was tested. The form matters too: creatine monohydrate is the form used in virtually every published trial. Alternative forms, creatine HCl, creatine ethyl ester, and so on, have not demonstrated superior brain uptake in head-to-head human studies.
When evaluating any product in this category, ask: what is the creatine dose, and is it monohydrate? If the label says "creatine blend" or lists a lower dose, it is not matching the evidence. Rōnin delivers 5, 000 mg micronised creatine monohydrate per daily serving, which matches the dose used in the RCTs cited above. The micronised form simply means smaller particle size for better dispersibility; the molecular compound is identical to what was tested.
For DHA, the GB-NHC authorised threshold is 250 mg/day. The trials reviewed by Minihane (2025) used doses ranging from 250 mg to over 1 g/day depending on the population and endpoint. The source form matters: algal DHA avoids the oxidation risk associated with fish oil and is appropriate for vegetarians. When reading a label, check whether the DHA figure is the actual DHA content or the total oil weight. These are not the same number, and many products conflate them. Rōnin specifies 650 mg algal DHA as the active DHA content, delivered as microencapsulated algal oil powder, which protects against oxidation during shelf life.
For citicoline, the trials that found effects on memory-related endpoints used 250 to 500 mg/day of CDP-choline. Rōnin includes 500 mg, which sits at the upper end of that studied range. I want to be clear: the large-scale human evidence in healthy adults is still limited, and I would not overstate what 500 mg of citicoline will do for someone already eating a choline-adequate diet. The research is ongoing.
One honest constraint worth naming: the GB-NHC authorised wording for DHA is specifically "maintenance of normal brain function, " not enhancement beyond normal. The regulatory ceiling is set there for a reason. Rōnin is built to that ceiling, not beyond it.
The ingredients with thinner evidence: what I'd say if you asked me directly
Several ingredients appear frequently in brain health products in the UK, and the evidence is genuinely mixed. I'd rather tell you that than pretend otherwise.
Ashwagandha
The trials that found effects on stress-related cognitive outcomes used 300 to 600 mg/day of a root extract standardised to withanolides. A leaf-and-root blend with no assay figure on the label is not the material that was tested. Research is ongoing and large-scale trials in cognitively healthy adults are limited. The stress-reduction data is more consistent than the direct cognitive-enhancement data, and conflating the two is a common industry mistake.
L-Theanine
The combination of L-theanine with caffeine has the most consistent short-term data for attention and reaction time. L-theanine alone at 200 mg may support a calmer attentional state, but the effect size in isolation is modest. Research is ongoing and large-scale human trials at this dose in isolation are limited. Rōnin includes 200 mg crystalline L-theanine, which matches the doses used in the available studies.
Rhodiola Rosea
Rhodiola has some interesting data on mental fatigue under stress. The evidence is preliminary and effect sizes vary considerably across trials. Research is ongoing and large-scale human trials in healthy adults are limited. The 350 mg root extract in Rōnin is within the range studied, but I would not make strong efficacy claims here.
Shilajit and Ubiquinol
Both are included in Rōnin at 500 mg purified shilajit extract and 100 mg ubiquinol (the reduced, more bioavailable form of CoQ10). Both have mechanistic rationale related to mitochondrial energy metabolism. Research is ongoing and large-scale human trials specifically in the context of brain health are limited. I include them because the safety profile is good and the mechanistic case is plausible, not because I can point to a definitive RCT in healthy adults.
I wrote about a similar approach to evaluating evidence in a very different context when I read about The Engineer Who Swam a Highland River to Understand the Tide. The principle is the same: first-hand data beats second-hand narrative every time.
How to read a brain health supplement label in the UK
Most people read supplement labels the wrong way. They look at the ingredient list and assume that if the ingredient is there, the product is doing what the ingredient does in the research. It usually isn't, for four reasons.
First: dose. The dose on the label is often a fraction of what was used in the trial. A product with 100 mg of creatine is not the same as one with 5, 000 mg. Both can legally say "contains creatine."
Second: form. Magnesium oxide and magnesium glycinate are both "magnesium." Their absorption profiles are very different. The same principle applies to creatine, DHA, CoQ10, and most other actives. The form determines bioavailability.
Third: standardisation. For botanical extracts, the active compound concentration matters. "Ashwagandha root extract" tells you almost nothing without a withanolide percentage. "KSM-66 root extract, 5% withanolides" tells you what you are actually getting.
Fourth: whether the dose figure is the active or the raw material weight. 650 mg algal oil is not the same as 650 mg DHA from algal oil. The DHA content of algal oil varies by strain and processing. A label that states the DHA figure explicitly is more trustworthy than one that states only the oil weight.
These are the questions worth asking of any lions mane benefits evidence article or any product page in this space. If the answer isn't on the label, that's information too.
What the 2026 creatine brain research says about our assumptions
Candow et al. (2026) published a paper asking a pointed question: have we put the cart before the horse on creatine and brain health? Their argument is worth engaging with honestly. Much of the brain creatine research to date has used surrogate endpoints, brain phosphocreatine concentration measured by MR spectroscopy, rather than hard clinical outcomes. The assumption that higher brain phosphocreatine reliably translates to better cognitive performance in healthy, well-nourished adults has not been definitively established.
I find this a useful corrective. The mechanistic case is solid. The surrogate evidence is solid. The clinical outcome evidence in healthy adults is promising but not yet conclusive. That is a different statement from "creatine doesn't work for brain health." It is also a different statement from "creatine definitely improves cognition in everyone." The truth sits somewhere in the middle, and being honest about that is more useful than picking a side for marketing purposes.
The populations where the evidence is strongest: vegetarians (lower baseline dietary creatine), adults over 60 (declining endogenous synthesis), and people under acute cognitive stress or sleep deprivation. If you fall into one of those groups, the signal is cleaner. If you are a 28-year-old omnivore getting adequate sleep, the marginal benefit is likely smaller.
Frequently asked questions
What is the best supplement for brain health in the UK?
No single ingredient is definitively "best, " but creatine monohydrate at 5 g/day and DHA at 250 mg or above have the strongest evidence base for brain-related outcomes in adults. Forbes et al. (2022) and the GB-NHC authorised claim for DHA are the two most solid reference points in the UK regulatory context.
Does creatine actually help with cognitive performance?
The evidence is most consistent in populations with lower baseline brain creatine: vegetarians, older adults, and people under sleep deprivation. Sandkühler et al. (2023) found statistically significant improvements in memory and attention in a randomised controlled crossover trial. In well-rested omnivores, the effect is smaller and less reliable.
Is DHA from algae as effective as DHA from fish oil?
Yes. DHA is DHA regardless of source. Algal DHA is the original source, since fish accumulate it by eating algae. Algal oil avoids the oxidation and contamination concerns sometimes associated with fish oil and is suitable for vegetarians. Minihane (2025) reviewed omega-3 brain health evidence without distinguishing source as a limiting factor.
How long does it take for brain health supplements to work?
Creatine brain saturation takes approximately 4 weeks of consistent daily supplementation at 5 g/day. DHA incorporation into neuronal membranes is a slower process, with studies typically running 12 to 24 weeks. Roschel et al. (2021) noted that brain phosphocreatine elevation is detectable at 4 weeks with consistent dosing.
Are brain health supplements regulated in the UK?
Food supplements are regulated under the Food Supplements (England) Regulations 2003 and equivalent devolved legislation. Health claims must be authorised under the GB-NHC register, maintained by the Food Standards Agency. Claims like "DHA contributes to the maintenance of normal brain function" are authorised; vague claims like "supports brain health" are not. Candow et al. (2023) note the regulatory gap between what the science suggests and what can legally be claimed.
What dose of citicoline is supported by evidence?
Trials that found memory-related effects in older adults and people with mild cognitive concerns used 250 to 500 mg/day of CDP-choline. Research in cognitively healthy younger adults is limited. The human data on this is thinner than for creatine or DHA, and I would not overstate the certainty of the effect in a healthy population. Forbes et al. (2022) focus primarily on creatine rather than citicoline for this reason.
My honest take
I built Rōnin because I kept reading the primary literature and finding a consistent gap between what the evidence supported and what products on the market actually delivered. Not in terms of exotic ingredients, but in terms of basic specification: the right dose, the right form, stated transparently on the label.
The KōJō Daily Formula includes 5, 000 mg micronised creatine monohydrate and 650 mg microencapsulated algal DHA per daily serving because those are the doses and forms that match the evidence. The citicoline is in at 500 mg CDP-choline because that's the upper end of the studied range, with the caveat that the healthy-adult data is still limited. The ashwagandha is a root extract at 600 mg, not a leaf-and-root blend with no assay figure. These are not marketing decisions. They are the result of reading the trials and asking what a product would have to contain to actually match what was tested.
What I am less certain about: whether the citicoline, rhodiola, shilajit, and ubiquinol make a meaningful difference for someone who is already eating well, sleeping adequately, and exercising regularly. The mechanistic case for each is plausible. The large-scale human trial evidence in healthy adults is limited. I include them because the safety profile is good and the cost of being wrong is low. But I won't pretend the evidence is stronger than it is.
The creatine and DHA are the ones I feel genuinely confident about. If you're a vegetarian, over 50, or regularly running a cognitive deficit from poor sleep, the creatine data is particularly relevant to you. If you're a well-rested omnivore in your twenties, the marginal benefit is probably smaller, and I'd rather tell you that than oversell it.
The field is moving. Candow et al. (2026) are right to push for harder clinical endpoints rather than surrogate markers. I'll update my position as the evidence updates. That's the deal.
This article is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement regimen.
References (9 studies)
- Forbes et al. (2022), Effects of Creatine Supplementation on Brain Function and Health. PMID 35267907.
- Candow et al. (2023), "Heads Up" for Creatine Supplementation and its Potential Applications for Brain Health and Function. PMID 37368234.
- Roschel et al. (2021), Creatine Supplementation and Brain Health. PMID 33578876.
- Loh et al. (2024), Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases. PMID 38360862.
- Sandkühler et al. (2023), The effects of creatine supplementation on cognitive performance, a randomised controlled study. PMID 37968687.
- Minihane (2025), Omega-3 fatty acids, brain health and the menopause. PMID 40444522.
- Candow et al. (2026), Creatine Supplementation and the Brain: Have We Put the Cart Before the Horse? PMID 41556609.
- Clayton et al. (2021), Palmitoylethanolamide: A Natural Compound for Health Management. PMID 34069940.
- Jeukendrup (2018), Periodized Nutrition for Athletes. PMID 28332115.
Photo via Unsplash
The morning note
One honest email a day, with the sunrise: the morning’s field note from the journal, a line to keep, and a quiet minute outside before the day starts. No discounts, no noise - unsubscribe any time.